Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

UV Absorbance Testing for Medical Devices: Standards, Methods, and Applications

UV absorbance testing is a critical chemical analysis method used to evaluate the safety and quality of medical devices by measuring the ultraviolet absorption of device extracts. This screening technique detects extractable and leachable organic substances released from polymeric materials, elastomers, and components used in infusion, transfusion, injection, and blood purification devices. This article provides a comprehensive technical overview of UV absorbance testing for medical devices, covering applicable standards, sample types, testing procedures, and regulatory applications.

Technical Overview

UV absorbance testing for medical devices is a spectroscopic screening method that quantifies the ultraviolet light absorbed by aqueous extracts prepared from device materials. When a medical device or its components come into contact with body fluids, drug solutions, or water for injection, low-molecular-weight organic substances such as residual monomers, oligomers, plasticizers, antioxidants, processing aids, and sterilization residues may migrate out of the material. Many of these organic compounds contain chromophore groups, such as aromatic rings, carbonyl groups, or conjugated double bonds, that absorb ultraviolet light in the wavelength range of approximately 190 to 400 nm.

By scanning the extract across the ultraviolet spectrum and measuring absorbance against a procedural blank, laboratories can obtain a sensitive, non-specific indicator of the total amount of UV-absorbing extractables present. Elevated absorbance values signal a higher burden of migrating organic chemicals, which may pose toxicological risk or affect the chemical quality of fluids delivered to patients. Because the method is rapid, reproducible, and instrumentally straightforward, it is widely used as a routine chemical safety control in the medical device industry and as part of regulatory submissions evaluated by accredited third-party laboratories.

The method is closely associated with standards such as GB/T 14233.1, which specifies chemical analysis methods for medical infusion, transfusion, and injection equipment, and is supported by sample preparation and chemical characterization frameworks including ISO 10993-12 and ISO 10993-18. Spectrophotometric measurement practices are further governed by reference documents such as USP General Chapter 851, ASTM E169, and ASTM E275.

Testing Samples

Disposable Infusion and Transfusion Sets

Infusion sets, blood transfusion sets, blood administration sets, and their accessories are among the most frequently tested product categories. These devices directly contact administered fluids for extended periods, so any extractable substances can enter the patient's bloodstream. Typical tested components include PVC or polyurethane tubing, drip chambers, injection sites, flow regulators, and filters.

Syringes and Injection Devices

Single-use sterile syringes, prefilled syringe components, needles hubs, and needle protectors are tested to verify that the barrel material, elastomer plunger tips, and lubricants, typically silicone oil, do not release excessive UV-absorbing substances into injected medications.

Intravenous Catheters and Interventional Tubing

Peripheral and central venous catheters, extension tubes, pressure tubing, and interventional device delivery systems are evaluated for chemical extractables released from polymeric shafts, coatings, and bonding agents under simulated clinical extraction conditions.

Blood Purification and Extracorporeal Circulation Devices

Hemodialyzers, hemofilters, blood tubing sets, oxygenators, and blood reservoirs contain large surface areas of membranes and polymers in direct contact with blood. UV absorbance screening is commonly applied to water extracts of these devices as an incoming quality control and batch release test.

Raw Materials, Components, and Packaging

Resins, masterbatches, elastomeric closures, septa, adhesives, and primary packaging materials intended for medical device manufacturing are tested during supplier qualification and incoming inspection to confirm material consistency before production.

Testing Items

Typical test items included in a UV absorbance evaluation program are listed below:

  • UV absorbance of aqueous device extracts by full-wavelength scanning, typically across 220 to 351 nm or another range defined by the applicable product standard
  • UV absorbance at specified single wavelengths, for example 230 nm, 254 nm, or 280 nm, where target classes of extractables exhibit characteristic absorption
  • Determination of maximum absorbance within the scanned range and comparison against the acceptance limit, commonly an absorbance of 0.1 or a limit specified in the relevant product standard
  • Procedural blank preparation and blank-corrected measurement to isolate the contribution of the device material
  • Extractable screening under standardized polar extraction conditions using purified water or other appropriate extraction media
  • Comparative studies between batches, suppliers, materials, or pre- and post-sterilization states

Testing Methods

Sample Preparation and Extraction

Test samples are prepared following the principles of GB/T 14233.1 and ISO 10993-12. Devices or components are cut, flushed, or immersed as appropriate to achieve a defined ratio of material surface area or mass to extraction medium volume. The most common extraction uses purified water as the polar medium, with extraction conditions such as 37 °C for 24 hours or an alternative validated condition specified by the product standard. A procedural blank consisting of the same extraction medium treated identically without the test sample is prepared in parallel.

Spectrophotometric Measurement

After extraction, the test extract is filtered or decanted if necessary to remove particulates, and its absorbance is measured using a calibrated ultraviolet-visible spectrophotometer equipped with quartz cuvettes of a 1 cm optical path length, since ordinary glass absorbs strongly in the UV region. The blank is used as the reference solution, and the extract is scanned across the specified wavelength range. Instrument performance, wavelength accuracy, and photometric accuracy are verified in accordance with practices such as ASTM E275, ASTM E169, and USP General Chapter 851.

Evaluation and Acceptance Criteria

The measured absorbance spectrum is compared with the acceptance criterion defined in the applicable standard or product specification. Under GB/T 14233.1, for example, the absorbance of the aqueous extract of many disposable devices must not exceed 0.1 at any wavelength within the specified UV range, unless the relevant product standard defines a different limit. Results exceeding the limit indicate an elevated level of UV-absorbing extractables and typically trigger further investigation, such as targeted chemical characterization under ISO 10993-18 or toxicological risk assessment under the ISO 10993 series.

Applications

UV absorbance testing serves multiple purposes throughout the medical device lifecycle:

  • Regulatory registration and market approval submissions, where chemical test data support device safety dossiers for national and regional regulatory frameworks
  • Routine batch release and in-process quality control for disposable infusion, transfusion, and injection devices
  • Raw material and supplier qualification programs for polymers, elastomers, and components
  • Sterilization process evaluation, including assessment of extractable changes after ethylene oxide sterilization or gamma and electron-beam irradiation
  • Change control and comparability studies when materials, formulations, processes, or suppliers are modified
  • Supporting data for chemical characterization and biological risk management under ISO 10993-18 and related biocompatibility standards
  • Verification testing performed by accredited third-party laboratories for import, export, and tender compliance

FAQ

What does a high UV absorbance result indicate?

A high absorbance value indicates that a greater quantity of UV-absorbing organic substances has migrated from the device material into the extraction medium. This may reflect residual monomers, additives, degradation products, or sterilization residues, and usually warrants further chemical identification and toxicological evaluation rather than representing a specific single substance.

Which standards govern UV absorbance testing of medical devices?

The primary method standard for disposable infusion, transfusion, and injection equipment is GB/T 14233.1. Sample preparation principles are defined in ISO 10993-12, chemical characterization is addressed in ISO 10993-18, and spectrophotometric techniques follow reference practices such as USP General Chapter 851, ASTM E169, and ASTM E275.

What are the typical extraction conditions?

The most common condition is extraction with purified water at 37 °C for 24 hours using a defined surface-area-to-volume or mass-to-volume ratio, with alternative temperatures and durations permitted when specified by the applicable product standard or justified by intended clinical use.

Why is a blank measurement necessary?

The procedural blank corrects for any absorbance contributed by the extraction medium, glassware, and handling steps. Blank correction ensures that the reported absorbance reflects only substances extracted from the device material, improving accuracy and reproducibility.

Can UV absorbance testing replace full chemical characterization?

No. UV absorbance is a non-specific screening method that quantifies total UV-absorbing extractables. It does not identify individual compounds. When screening results are elevated or when a full risk assessment is required, targeted analytical methods such as chromatography and mass spectrometry conducted under ISO 10993-18 are used to identify and quantify specific extractables.

How much sample is required for testing?

Sample requirements depend on the device type and the surface-area-to-volume ratio prescribed by the standard, but testing is generally performed on complete devices or representative components, with replicate samples recommended to account for material variability.

Why Choose ZKGX?

  • State-of-the-art analytical equipment
  • Highly qualified scientific team
  • Fast turnaround time
  • Competitive pricing